The US Food and Drug Administration has granted a group of researchers approval to proceed with the use of the controversial drug psilocybin, a psychedelic compound naturally produced in about 200 species of mushrooms, to treat patients suffering from treatment-resistant depression. This comes as welcome news for researchers that study psychedelic drugs, as current drug laws inhibit the study into the potential medical effects that the forbidden fungus may have to offer.
read more

Medical researchers have saved the life of a seven-year-old boy by growing genetically-modified replacement skin for him. The young German boy suffered from a deadly congenital condition called epidermolysis bullosa, a condition that cases the sufferer’s skin to tear and blister, as if it had been burned. The procedure not only saved his life, but he’s now able to participate in sports with his classmates.

By 2015 the patient had been admitted to the burns unit at Bochum Children’s Hospital in Germany: at that point, two-thirds of his skin was either was either badly damaged or outright missing, and traditional treatments failed to yield results, including skin grafts from a donor.
read more

 Researchers in Belgium have developed a technique that allows coma patients that are in a minimally-conscious state to become aware enough to communicate — for up to a week — using mild electrical stimulation to their brains.

Building on the results of a 2014 study that showed that electrical stimulation of the brain could briefly help raise the state of awareness in coma patients, a research team from Belgium’s University of Liège performed a similar experiment using longer sessions, where 16 participants, either in a minimally conscious or vegetative state, were given 20-minute treatments for five days.
read more